ChemoCentryx&#44; Inc. Blog | Talkmarkets

Latest Posts

Check Your Portfolio For Small Cap Weighting: Growth, Innovation Or Speculation?

Article By: Rod Raynovich

Monday, August 15, 2022 5:12 AM EDT

The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring biotech small cap performance.

In this article: CYRX, QDEL, IWM, XBI, CCXI, EVH, ARKG, MRTX

Read

Small Cap Biotechs Perk Up On Dealmaking

Article By: Rod Raynovich

Saturday, August 6, 2022 9:38 PM EDT

With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology.

In this article: PFE, AMGN, XBI, CCXI, GBT Also: MRNA, CRSP

Read

Futures Slide As Soaring Oil Nears $85

Article By: Tyler Durden

Monday, October 11, 2021 9:05 AM EDT

While cash bonds may be closed, one can easily extrapolate where they would be trading based on TSY futures which are currently trading at a 1.65% equivalent.

In this article: BNO, CVX, OXY, XOM, CCXI, KERN, NET, HOOD, LCID Also: AAPL, AMZN, MSFT

Read

Biotech Losers In 2021 That Could Bounce Big In The Second Half

Article By: Benzinga

Saturday, July 3, 2021 5:14 PM EDT

Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to come back stronger:

In this article: CCXI, IMRA, IMVT, ATHA, SGTX

Read